Home | Welcome to Contract Pharma   
Last Updated Thursday, June 20 2013
Print RSS Feed

Breaking News

Related Searches:

September 11, 2008
Akorn, Inc. has entered into a 10-year exclusive contract manufacturing supply agreement with an undisclosed ophthalmic company. Under the terms of the agreement, Akorn will be responsible for the development, manufacturing and supply of two new opht…  Read More »

September 10, 2008
Sanofi-Aventis has named Chris Viehbacher chief executive officer of the Group, effective December 1st, 2008. He succeeds Gerard Fur, who will continue to provide general management of the Group in the scientific area.     Mr. Vieh…  Read More »

September 10, 2008
Cellzome, Inc. and GlaxoSmithKline entered a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases. The alliance gives GSK access to Cellzome's expertise in identifying and deve…  Read More »

September 10, 2008
Azopharma Product Development Group announced the successful FDA audit of its Cyanta Analytical Laboratories facility in Maryland Heights, MO. The audit occurred from Aug 19-20 and produced no 483s or other major observations.    …  Read More »

September 10, 2008
Charles River Laboratories has completed the acquisition of privately held NewLab BioQuality AG, a Dusseldorf, Germany-based provider of safety and quality control services to biopharmaceutical clients. NewLab joins Charles River Biopharmaceutical Se…  Read More »

September 9, 2008
Pfizer will globally withdraw all dalbavancin marketing applications for the treatment of complicated skin and skin structure infections in adults, including the U.S. NDA and the European MAA.     Following feedback from regulatory…  Read More »

September 9, 2008
Bilcare Global Clinical Supplies has enhanced its global Phase III capabilities. The company has upgraded its Kalish large-scale bottling line at its U.S. facility and invested in new Pentapack blistering technology for expanded packaging capabilitie…  Read More »

September 9, 2008
West has completed expansion work at its Kinston, NC manufacturing facility. The expanded plant provides additional compounding and custom manufacturing capabilities and will bring more than 150 new jobs to Kinston and surrounding communities. The fa…  Read More »

September 9, 2008
Thierry Amat has been appointed chief financial officer of Aptuit, Inc. Mr. Amat will oversee the financial and information technology departments. He has more than 20 years of financial management experience in publicly traded companies as well as k…  Read More »

September 8, 2008
The FDA has granted supplemental NDA approval for Akorn, Inc.'s IC-Green for Injection, USP. This approval is Akorn’s first lyophilized product approval for manufacture in its Decatur, IL production facility.     The company h…  Read More »

September 8, 2008
Bosch's Packaging Technology Division plans to acquire Paal Verpackungsmaschinen GmbH & Co. KG, based in Remshalden near Stuttgart. The purchase price was not disclosed.       Paal is a packaging and automation specialist t…  Read More »

September 8, 2008
The FDA has accepted data submitted from Bridge Laboratories' Beijing facility on behalf of a U.S. biotech client. The GLP nonhuman primate toxicology study data was generated and submitted as part of an IND package to the FDA. Bridge’s Beijing…  Read More »

September 5, 2008
Cirrus Pharmaceuticals, Inc. has expanded its current capacity for stability storage with the addition of 3 LUWA walk-in stability chambers. The company will add three large capacity, cGMP compliant chambers, each with 1,100 cubic feet of storage spa…  Read More »

September 5, 2008
WellSpring Pharmaceutical Corp. has expanded its consumer health care product line with the acquisition of several OTC products from McNeil Consumer Healthcare Division. In an all-cash transaction, WellSpring has purchased U.S. rights to Micatin (ant…  Read More »

September 5, 2008
Patheon 3Q Revenues: $195.0 million (+18%) 3Q Loss: $14.7 million (loss of $63.1 million in 3Q07) YTD Revenues: $545.1 million (+15%) YTD Loss: $38.3 million (loss of $87.1 million YTD07) Comments: Commercial Manufacturing revenues w…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On